Gregory Divis | executive |
Richard Kim | executive |
Thomas McHugh | executive |
Ami Fadia | analyst |
Guofang Li | analyst |
Matthew Kaplan | analyst |
François Brisebois | analyst |
Jennifer Gudeman | executive |
David Amsellem | analyst |
Chase Knickerbocker | analyst |
Greetings, and welcome to the Avadel Pharmaceuticals Third Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce Austin Murtagh with Stern Investor Relations.
You may begin.
Good morning, and thank you for joining us on our conference call to discuss Avadel's Third Quarter 2023 Earnings.